$1.735
-0.776 (-44.75%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BCAB Prediction & Forecast by Similar Chart Analysis
Alphio's BCAB stock price prediction model matches the current Bioatla Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+0.52%). The 1-week path is $1.77 (+2.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bioatla Inc Stock?
BioAtla Inc is not a good buy right now due to its significant financial losses and poor stock performance. The current price is $1.74, which is a staggering 96.60% lower than its 1-year high of $71.50. Furthermore, the company has reported a negative net income of -$6,344,000 in Q1 2026, and a forward P/E ratio of 0 indicates uncertainty about future earnings. The recent hedge fund selling activity has increased by 760.39%, signaling a lack of confidence among institutional investors, which adds to the risk of holding this stock.
BCAB stock price ended at $1.74 on Friday, after losing -44.75%
Bioatla Inc (BCAB) last closed at $1.735, losing -44.75%. These facts feed the 1-day and 1-week BCAB price prediction above.
Forecast Drivers
Bioatla Inc (BCAB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BCAB, ranked by similarity.
Seasonality analysis for BCAB
Historically the probability of a positive November return for BCAB is 48.72%. December offers the highest probability of a positive month at 48.84%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BCAB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.40 | $0.43 | $0.51 | -75.50% |
| Dec 2026 | $0.32 | $0.39 | $0.43 | -77.60% |
In 2026, Bioatla Inc (BCAB) is projected to range from $0.32 to $0.51.
Bioatla Inc 2026 monthly forecast
In Nov 2026, Bioatla Inc is projected to average $0.43, with a low of $0.40 and high of $0.51.
In Dec 2026, Bioatla Inc is projected to average $0.39, with a low of $0.32 and high of $0.43.
Related articles
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.